id	sid	tid	token	lemma	pos
dhrp-12	1	1	2021	2021	NUM
dhrp-12	1	2	,	,	PUNCT
dhrp-12	1	3	vol	vol	NOUN
dhrp-12	1	4	.	.	NOUN
dhrp-12	1	5	1	1	NUM
dhrp-12	1	6	(	(	PUNCT
dhrp-12	1	7	s2	s2	PROPN
dhrp-12	1	8	)	)	PUNCT
dhrp-12	1	9	1	1	NUM
dhrp-12	1	10	-	-	SYM
dhrp-12	1	11	2	2	NUM
dhrp-12	1	12	https://doi.org/10.47488/dhrp.v1is2.12	https://doi.org/10.47488/dhrp.v1is2.12	NOUN
dhrp-12	1	13	http://dhrproceedings.org	http://dhrproceedings.org	PROPN
dhrp-12	1	14	1	1	NUM
dhrp-12	1	15	©	©	PROPN
dhrp-12	1	16	dhr	dhr	PROPN
dhrp-12	1	17	health	health	PROPN
dhrp-12	1	18	institute	institute	PROPN
dhrp-12	1	19	for	for	ADP
dhrp-12	1	20	research	research	NOUN
dhrp-12	1	21	and	and	CCONJ
dhrp-12	1	22	development	development	NOUN
dhrp-12	1	23	editorial	editorial	NOUN
dhrp-12	1	24	is	be	AUX
dhrp-12	1	25	the	the	DET
dhrp-12	1	26	public	public	ADJ
dhrp-12	1	27	outcry	outcry	NOUN
dhrp-12	1	28	for	for	ADP
dhrp-12	1	29	johnson	johnson	PROPN
dhrp-12	1	30	&	&	CCONJ
dhrp-12	1	31	johnson	johnson	PROPN
dhrp-12	1	32	jansen	jansen	PROPN
dhrp-12	1	33	’s	’s	PART
dhrp-12	1	34	covid-19	covid-19	PROPN
dhrp-12	1	35	vaccine	vaccine	NOUN
dhrp-12	1	36	causing	cause	VERB
dhrp-12	1	37	blood	blood	NOUN
dhrp-12	1	38	clots	clot	NOUN
dhrp-12	1	39	justified	justify	VERB
dhrp-12	1	40	?	?	PUNCT
dhrp-12	2	1	as	as	ADP
dhrp-12	2	2	of	of	ADP
dhrp-12	2	3	today	today	NOUN
dhrp-12	2	4	,	,	PUNCT
dhrp-12	2	5	globally	globally	ADV
dhrp-12	2	6	,	,	PUNCT
dhrp-12	2	7	over	over	ADP
dhrp-12	2	8	139	139	NUM
dhrp-12	2	9	million	million	NUM
dhrp-12	2	10	people	people	NOUN
dhrp-12	2	11	have	have	AUX
dhrp-12	2	12	been	be	AUX
dhrp-12	2	13	infected	infect	VERB
dhrp-12	2	14	with	with	ADP
dhrp-12	2	15	sars	sar	NOUN
dhrp-12	2	16	-	-	PUNCT
dhrp-12	2	17	cov-2	cov-2	PART
dhrp-12	2	18	virus	virus	NOUN
dhrp-12	2	19	and	and	CCONJ
dhrp-12	2	20	over	over	ADP
dhrp-12	2	21	2.9	2.9	NUM
dhrp-12	2	22	million	million	NUM
dhrp-12	2	23	have	have	AUX
dhrp-12	2	24	died	die	VERB
dhrp-12	2	25	as	as	ADP
dhrp-12	2	26	a	a	DET
dhrp-12	2	27	result	result	NOUN
dhrp-12	2	28	of	of	ADP
dhrp-12	2	29	this	this	DET
dhrp-12	2	30	infection	infection	NOUN
dhrp-12	2	31	(	(	PUNCT
dhrp-12	2	32	1	1	NUM
dhrp-12	2	33	)	)	PUNCT
dhrp-12	2	34	.	.	PUNCT
dhrp-12	3	1	in	in	ADP
dhrp-12	3	2	the	the	DET
dhrp-12	3	3	united	united	PROPN
dhrp-12	3	4	states	states	PROPN
dhrp-12	3	5	,	,	PUNCT
dhrp-12	3	6	over	over	ADP
dhrp-12	3	7	31	31	NUM
dhrp-12	3	8	million	million	NUM
dhrp-12	3	9	people	people	NOUN
dhrp-12	3	10	have	have	AUX
dhrp-12	3	11	been	be	AUX
dhrp-12	3	12	diagnosed	diagnose	VERB
dhrp-12	3	13	with	with	ADP
dhrp-12	3	14	covid-19	covid-19	PROPN
dhrp-12	3	15	,	,	PUNCT
dhrp-12	3	16	a	a	DET
dhrp-12	3	17	disease	disease	NOUN
dhrp-12	3	18	caused	cause	VERB
dhrp-12	3	19	by	by	ADP
dhrp-12	3	20	sars	sar	NOUN
dhrp-12	3	21	-	-	PUNCT
dhrp-12	3	22	cov-2	cov-2	PART
dhrp-12	3	23	virus	virus	NOUN
dhrp-12	3	24	and	and	CCONJ
dhrp-12	3	25	over	over	ADP
dhrp-12	3	26	565,000	565,000	NUM
dhrp-12	3	27	people	people	NOUN
dhrp-12	3	28	have	have	AUX
dhrp-12	3	29	encountered	encounter	VERB
dhrp-12	3	30	a	a	DET
dhrp-12	3	31	fatal	fatal	ADJ
dhrp-12	3	32	outcome	outcome	NOUN
dhrp-12	3	33	.	.	PUNCT
dhrp-12	4	1	on	on	ADP
dhrp-12	4	2	february	february	PROPN
dhrp-12	4	3	27	27	NUM
dhrp-12	4	4	,	,	PUNCT
dhrp-12	4	5	2021	2021	NUM
dhrp-12	4	6	,	,	PUNCT
dhrp-12	4	7	the	the	DET
dhrp-12	4	8	us	us	PROPN
dhrp-12	4	9	food	food	PROPN
dhrp-12	4	10	&	&	CCONJ
dhrp-12	4	11	drug	drug	PROPN
dhrp-12	4	12	administration	administration	PROPN
dhrp-12	4	13	(	(	PUNCT
dhrp-12	4	14	fda	fda	PROPN
dhrp-12	4	15	)	)	PUNCT
dhrp-12	4	16	approved	approve	VERB
dhrp-12	4	17	the	the	DET
dhrp-12	4	18	use	use	NOUN
dhrp-12	4	19	of	of	ADP
dhrp-12	4	20	johnson	johnson	PROPN
dhrp-12	4	21	&	&	CCONJ
dhrp-12	4	22	johnson	johnson	PROPN
dhrp-12	4	23	(	(	PUNCT
dhrp-12	4	24	j&j	j&j	PROPN
dhrp-12	4	25	)	)	PUNCT
dhrp-12	4	26	jansen	jansen	PROPN
dhrp-12	4	27	covid-19	covid-19	PROPN
dhrp-12	4	28	vaccine	vaccine	NOUN
dhrp-12	4	29	for	for	ADP
dhrp-12	4	30	individuals	individual	NOUN
dhrp-12	4	31	18	18	NUM
dhrp-12	4	32	years	year	NOUN
dhrp-12	4	33	of	of	ADP
dhrp-12	4	34	age	age	NOUN
dhrp-12	4	35	or	or	CCONJ
dhrp-12	4	36	older	old	ADJ
dhrp-12	4	37	under	under	ADP
dhrp-12	4	38	emergency	emergency	NOUN
dhrp-12	4	39	use	use	NOUN
dhrp-12	4	40	authorization	authorization	NOUN
dhrp-12	4	41	(	(	PUNCT
dhrp-12	4	42	2	2	NUM
dhrp-12	4	43	)	)	PUNCT
dhrp-12	4	44	.	.	PUNCT
dhrp-12	5	1	while	while	SCONJ
dhrp-12	5	2	the	the	DET
dhrp-12	5	3	j&j	j&j	PROPN
dhrp-12	5	4	jansen	jansen	PROPN
dhrp-12	5	5	covid-19	covid-19	PROPN
dhrp-12	5	6	vaccine	vaccine	NOUN
dhrp-12	5	7	only	only	ADV
dhrp-12	5	8	had	have	VERB
dhrp-12	5	9	72	72	NUM
dhrp-12	5	10	%	%	NOUN
dhrp-12	5	11	efficacy	efficacy	NOUN
dhrp-12	5	12	,	,	PUNCT
dhrp-12	5	13	a	a	DET
dhrp-12	5	14	single	single	ADJ
dhrp-12	5	15	shot	shot	NOUN
dhrp-12	5	16	of	of	ADP
dhrp-12	5	17	this	this	DET
dhrp-12	5	18	vaccine	vaccine	NOUN
dhrp-12	5	19	was	be	AUX
dhrp-12	5	20	100	100	NUM
dhrp-12	5	21	%	%	NOUN
dhrp-12	5	22	effective	effective	ADJ
dhrp-12	5	23	in	in	ADP
dhrp-12	5	24	preventing	prevent	VERB
dhrp-12	5	25	death	death	NOUN
dhrp-12	5	26	and	and	CCONJ
dhrp-12	5	27	hospitalization	hospitalization	NOUN
dhrp-12	5	28	caused	cause	VERB
dhrp-12	5	29	by	by	ADP
dhrp-12	5	30	covid-19	covid-19	PROPN
dhrp-12	5	31	in	in	ADP
dhrp-12	5	32	clinical	clinical	ADJ
dhrp-12	5	33	trials	trial	NOUN
dhrp-12	5	34	(	(	PUNCT
dhrp-12	5	35	3	3	NUM
dhrp-12	5	36	)	)	PUNCT
dhrp-12	5	37	.	.	PUNCT
dhrp-12	6	1	since	since	SCONJ
dhrp-12	6	2	its	its	PRON
dhrp-12	6	3	approval	approval	NOUN
dhrp-12	6	4	,	,	PUNCT
dhrp-12	6	5	it	it	PRON
dhrp-12	6	6	is	be	AUX
dhrp-12	6	7	estimated	estimate	VERB
dhrp-12	6	8	that	that	SCONJ
dhrp-12	6	9	over	over	ADP
dhrp-12	6	10	6.8	6.8	NUM
dhrp-12	6	11	million	million	NUM
dhrp-12	6	12	people	people	NOUN
dhrp-12	6	13	in	in	ADP
dhrp-12	6	14	the	the	DET
dhrp-12	6	15	united	united	PROPN
dhrp-12	6	16	states	states	PROPN
dhrp-12	6	17	have	have	AUX
dhrp-12	6	18	been	be	AUX
dhrp-12	6	19	vaccinated	vaccinate	VERB
dhrp-12	6	20	with	with	ADP
dhrp-12	6	21	j&j	j&j	PROPN
dhrp-12	6	22	jansen	jansen	PROPN
dhrp-12	6	23	covid-19	covid-19	PROPN
dhrp-12	6	24	vaccine	vaccine	NOUN
dhrp-12	6	25	(	(	PUNCT
dhrp-12	6	26	4	4	NUM
dhrp-12	6	27	)	)	PUNCT
dhrp-12	6	28	.	.	PUNCT
dhrp-12	7	1	recent	recent	ADJ
dhrp-12	7	2	reports	report	NOUN
dhrp-12	7	3	have	have	AUX
dhrp-12	7	4	confirmed	confirm	VERB
dhrp-12	7	5	blood	blood	NOUN
dhrp-12	7	6	clots	clot	NOUN
dhrp-12	7	7	in	in	ADP
dhrp-12	7	8	six	six	NUM
dhrp-12	7	9	individuals	individual	NOUN
dhrp-12	7	10	who	who	PRON
dhrp-12	7	11	have	have	AUX
dhrp-12	7	12	received	receive	VERB
dhrp-12	7	13	j&j	j&j	PROPN
dhrp-12	7	14	jansen	jansen	PROPN
dhrp-12	7	15	covid19	covid19	PROPN
dhrp-12	7	16	vaccine	vaccine	NOUN
dhrp-12	7	17	(	(	PUNCT
dhrp-12	7	18	4	4	NUM
dhrp-12	7	19	)	)	PUNCT
dhrp-12	7	20	.	.	PUNCT
dhrp-12	8	1	all	all	PRON
dhrp-12	8	2	of	of	ADP
dhrp-12	8	3	these	these	DET
dhrp-12	8	4	six	six	NUM
dhrp-12	8	5	vaccine	vaccine	NOUN
dhrp-12	8	6	recipients	recipient	NOUN
dhrp-12	8	7	were	be	AUX
dhrp-12	8	8	females	female	NOUN
dhrp-12	8	9	between	between	ADP
dhrp-12	8	10	the	the	DET
dhrp-12	8	11	ages	age	NOUN
dhrp-12	8	12	of	of	ADP
dhrp-12	8	13	18	18	NUM
dhrp-12	8	14	and	and	CCONJ
dhrp-12	8	15	48	48	NUM
dhrp-12	8	16	years	year	NOUN
dhrp-12	8	17	;	;	PUNCT
dhrp-12	8	18	symptoms	symptom	NOUN
dhrp-12	8	19	occurred	occur	VERB
dhrp-12	8	20	6	6	NUM
dhrp-12	8	21	-	-	SYM
dhrp-12	8	22	13	13	NUM
dhrp-12	8	23	days	day	NOUN
dhrp-12	8	24	after	after	ADP
dhrp-12	8	25	vaccination	vaccination	NOUN
dhrp-12	8	26	,	,	PUNCT
dhrp-12	8	27	and	and	CCONJ
dhrp-12	8	28	all	all	PRON
dhrp-12	8	29	had	have	VERB
dhrp-12	8	30	a	a	DET
dhrp-12	8	31	previous	previous	ADJ
dhrp-12	8	32	diagnosis	diagnosis	NOUN
dhrp-12	8	33	of	of	ADP
dhrp-12	8	34	suffering	suffer	VERB
dhrp-12	8	35	from	from	ADP
dhrp-12	8	36	thrombocytopenia	thrombocytopenia	PROPN
dhrp-12	8	37	.	.	PUNCT
dhrp-12	9	1	the	the	DET
dhrp-12	9	2	form	form	NOUN
dhrp-12	9	3	of	of	ADP
dhrp-12	9	4	blood	blood	NOUN
dhrp-12	9	5	clotting	clotting	NOUN
dhrp-12	9	6	reported	report	VERB
dhrp-12	9	7	in	in	ADP
dhrp-12	9	8	the	the	DET
dhrp-12	9	9	recipients	recipient	NOUN
dhrp-12	9	10	of	of	ADP
dhrp-12	9	11	j&j	j&j	PROPN
dhrp-12	9	12	jansen	jansen	PROPN
dhrp-12	9	13	covid-19	covid-19	PROPN
dhrp-12	9	14	vaccine	vaccine	NOUN
dhrp-12	9	15	is	be	AUX
dhrp-12	9	16	known	know	VERB
dhrp-12	9	17	as	as	ADP
dhrp-12	9	18	the	the	DET
dhrp-12	9	19	cerebral	cerebral	ADJ
dhrp-12	9	20	venous	venous	ADJ
dhrp-12	9	21	and	and	CCONJ
dhrp-12	9	22	sinus	sinus	NOUN
dhrp-12	9	23	thrombosis	thrombosis	NOUN
dhrp-12	9	24	(	(	PUNCT
dhrp-12	9	25	cvst	cvst	PROPN
dhrp-12	9	26	)	)	PUNCT
dhrp-12	9	27	,	,	PUNCT
dhrp-12	9	28	a	a	DET
dhrp-12	9	29	form	form	NOUN
dhrp-12	9	30	of	of	ADP
dhrp-12	9	31	disease	disease	NOUN
dhrp-12	9	32	only	only	ADV
dhrp-12	9	33	encountered	encounter	VERB
dhrp-12	9	34	in	in	ADP
dhrp-12	9	35	less	less	ADJ
dhrp-12	9	36	than	than	ADP
dhrp-12	9	37	1	1	NUM
dhrp-12	9	38	%	%	NOUN
dhrp-12	9	39	of	of	ADP
dhrp-12	9	40	strokes	stroke	NOUN
dhrp-12	9	41	(	(	PUNCT
dhrp-12	9	42	5	5	NUM
dhrp-12	9	43	)	)	PUNCT
dhrp-12	9	44	.	.	PUNCT
dhrp-12	10	1	while	while	SCONJ
dhrp-12	10	2	it	it	PRON
dhrp-12	10	3	is	be	AUX
dhrp-12	10	4	a	a	DET
dhrp-12	10	5	rare	rare	ADJ
dhrp-12	10	6	and	and	CCONJ
dhrp-12	10	7	severe	severe	ADJ
dhrp-12	10	8	form	form	NOUN
dhrp-12	10	9	of	of	ADP
dhrp-12	10	10	cvst	cvst	PROPN
dhrp-12	10	11	,	,	PUNCT
dhrp-12	10	12	it	it	PRON
dhrp-12	10	13	is	be	AUX
dhrp-12	10	14	important	important	ADJ
dhrp-12	10	15	to	to	PART
dhrp-12	10	16	recognize	recognize	VERB
dhrp-12	10	17	that	that	SCONJ
dhrp-12	10	18	it	it	PRON
dhrp-12	10	19	was	be	AUX
dhrp-12	10	20	only	only	ADV
dhrp-12	10	21	witnessed	witness	VERB
dhrp-12	10	22	in	in	ADP
dhrp-12	10	23	0.000009	0.000009	NUM
dhrp-12	10	24	%	%	NOUN
dhrp-12	10	25	of	of	ADP
dhrp-12	10	26	j&j	j&j	PROPN
dhrp-12	10	27	jansen	jansen	PROPN
dhrp-12	10	28	covid-19	covid-19	PROPN
dhrp-12	10	29	vaccine	vaccine	NOUN
dhrp-12	10	30	recipients	recipient	NOUN
dhrp-12	10	31	.	.	PUNCT
dhrp-12	11	1	based	base	VERB
dhrp-12	11	2	on	on	ADP
dhrp-12	11	3	these	these	DET
dhrp-12	11	4	early	early	ADJ
dhrp-12	11	5	reports	report	NOUN
dhrp-12	11	6	,	,	PUNCT
dhrp-12	11	7	on	on	ADP
dhrp-12	11	8	april	april	PROPN
dhrp-12	11	9	13	13	NUM
dhrp-12	11	10	,	,	PUNCT
dhrp-12	11	11	2021	2021	NUM
dhrp-12	11	12	,	,	PUNCT
dhrp-12	11	13	both	both	PRON
dhrp-12	11	14	fda	fda	PROPN
dhrp-12	11	15	and	and	CCONJ
dhrp-12	11	16	the	the	DET
dhrp-12	11	17	center	center	NOUN
dhrp-12	11	18	for	for	ADP
dhrp-12	11	19	disease	disease	NOUN
dhrp-12	11	20	control	control	PROPN
dhrp-12	11	21	&	&	CCONJ
dhrp-12	11	22	prevention	prevention	PROPN
dhrp-12	11	23	(	(	PUNCT
dhrp-12	11	24	cdc	cdc	PROPN
dhrp-12	11	25	)	)	PUNCT
dhrp-12	11	26	recommended	recommend	VERB
dhrp-12	11	27	to	to	PART
dhrp-12	11	28	pause	pause	VERB
dhrp-12	11	29	the	the	DET
dhrp-12	11	30	use	use	NOUN
dhrp-12	11	31	of	of	ADP
dhrp-12	11	32	j&j	j&j	PROPN
dhrp-12	11	33	jansen	jansen	PROPN
dhrp-12	11	34	covid-19	covid-19	PROPN
dhrp-12	11	35	vaccine	vaccine	NOUN
dhrp-12	11	36	pending	pende	VERB
dhrp-12	11	37	further	further	ADJ
dhrp-12	11	38	review	review	NOUN
dhrp-12	11	39	and	and	CCONJ
dhrp-12	11	40	to	to	PART
dhrp-12	11	41	convene	convene	VERB
dhrp-12	11	42	a	a	DET
dhrp-12	11	43	meeting	meeting	NOUN
dhrp-12	11	44	of	of	ADP
dhrp-12	11	45	the	the	DET
dhrp-12	11	46	advisory	advisory	ADJ
dhrp-12	11	47	committee	committee	NOUN
dhrp-12	11	48	on	on	ADP
dhrp-12	11	49	immunization	immunization	NOUN
dhrp-12	11	50	practices	practice	NOUN
dhrp-12	11	51	(	(	PUNCT
dhrp-12	11	52	acip	acip	NOUN
dhrp-12	11	53	)	)	PUNCT
dhrp-12	11	54	to	to	PART
dhrp-12	11	55	review	review	VERB
dhrp-12	11	56	the	the	DET
dhrp-12	11	57	available	available	ADJ
dhrp-12	11	58	clinical	clinical	ADJ
dhrp-12	11	59	data	datum	NOUN
dhrp-12	11	60	to	to	PART
dhrp-12	11	61	make	make	VERB
dhrp-12	11	62	further	further	ADJ
dhrp-12	11	63	determination	determination	NOUN
dhrp-12	11	64	(	(	PUNCT
dhrp-12	11	65	4	4	NUM
dhrp-12	11	66	)	)	PUNCT
dhrp-12	11	67	.	.	PUNCT
dhrp-12	12	1	the	the	DET
dhrp-12	12	2	acip	acip	PROPN
dhrp-12	12	3	met	meet	VERB
dhrp-12	12	4	on	on	ADP
dhrp-12	12	5	april	april	PROPN
dhrp-12	12	6	16	16	NUM
dhrp-12	12	7	,	,	PUNCT
dhrp-12	12	8	2021	2021	NUM
dhrp-12	12	9	and	and	CCONJ
dhrp-12	12	10	recommended	recommend	VERB
dhrp-12	12	11	to	to	PART
dhrp-12	12	12	extend	extend	VERB
dhrp-12	12	13	the	the	DET
dhrp-12	12	14	pause	pause	NOUN
dhrp-12	12	15	to	to	PART
dhrp-12	12	16	allow	allow	VERB
dhrp-12	12	17	for	for	ADP
dhrp-12	12	18	additional	additional	ADJ
dhrp-12	12	19	review	review	NOUN
dhrp-12	12	20	of	of	ADP
dhrp-12	12	21	available	available	ADJ
dhrp-12	12	22	clinical	clinical	ADJ
dhrp-12	12	23	data	datum	NOUN
dhrp-12	12	24	(	(	PUNCT
dhrp-12	12	25	6	6	NUM
dhrp-12	12	26	)	)	PUNCT
dhrp-12	12	27	.	.	PUNCT
dhrp-12	13	1	while	while	SCONJ
dhrp-12	13	2	these	these	DET
dhrp-12	13	3	precautionary	precautionary	ADJ
dhrp-12	13	4	actions	action	NOUN
dhrp-12	13	5	are	be	AUX
dhrp-12	13	6	justified	justify	VERB
dhrp-12	13	7	,	,	PUNCT
dhrp-12	13	8	the	the	DET
dhrp-12	13	9	observed	observed	ADJ
dhrp-12	13	10	complication	complication	NOUN
dhrp-12	13	11	following	follow	VERB
dhrp-12	13	12	j&j	j&j	PROPN
dhrp-12	13	13	jansen	jansen	PROPN
dhrp-12	13	14	covid-19	covid-19	PROPN
dhrp-12	13	15	vaccination	vaccination	NOUN
dhrp-12	13	16	must	must	AUX
dhrp-12	13	17	be	be	AUX
dhrp-12	13	18	viewed	view	VERB
dhrp-12	13	19	in	in	ADP
dhrp-12	13	20	light	light	NOUN
dhrp-12	13	21	of	of	ADP
dhrp-12	13	22	the	the	DET
dhrp-12	13	23	fact	fact	NOUN
dhrp-12	13	24	that	that	SCONJ
dhrp-12	13	25	the	the	DET
dhrp-12	13	26	risk	risk	NOUN
dhrp-12	13	27	of	of	ADP
dhrp-12	13	28	developing	develop	VERB
dhrp-12	13	29	thromboembolism	thromboembolism	NOUN
dhrp-12	13	30	(	(	PUNCT
dhrp-12	13	31	te	te	PROPN
dhrp-12	13	32	)	)	PUNCT
dhrp-12	13	33	following	follow	VERB
dhrp-12	13	34	infection	infection	NOUN
dhrp-12	13	35	with	with	ADP
dhrp-12	13	36	sars	sar	NOUN
dhrp-12	13	37	-	-	PUNCT
dhrp-12	13	38	cov-2	cov-2	PART
dhrp-12	13	39	and	and	CCONJ
dhrp-12	13	40	observed	observed	ADJ
dhrp-12	13	41	mortality	mortality	NOUN
dhrp-12	13	42	is	be	AUX
dhrp-12	13	43	much	much	ADV
dhrp-12	13	44	higher	high	ADJ
dhrp-12	13	45	(	(	PUNCT
dhrp-12	13	46	7	7	NUM
dhrp-12	13	47	)	)	PUNCT
dhrp-12	13	48	.	.	PUNCT
dhrp-12	14	1	as	as	SCONJ
dhrp-12	14	2	reported	report	VERB
dhrp-12	14	3	by	by	ADP
dhrp-12	14	4	malas	malas	PROPN
dhrp-12	14	5	,	,	PUNCT
dhrp-12	14	6	et.al	et.al	PROPN
dhrp-12	14	7	,	,	PUNCT
dhrp-12	14	8	overall	overall	ADJ
dhrp-12	14	9	arterial	arterial	NOUN
dhrp-12	14	10	te	te	ADP
dhrp-12	14	11	rate	rate	NOUN
dhrp-12	14	12	in	in	ADP
dhrp-12	14	13	patients	patient	NOUN
dhrp-12	14	14	with	with	ADP
dhrp-12	14	15	covid-19	covid-19	PROPN
dhrp-12	14	16	was	be	AUX
dhrp-12	14	17	2	2	NUM
dhrp-12	14	18	%	%	NOUN
dhrp-12	14	19	with	with	ADP
dhrp-12	14	20	overall	overall	ADJ
dhrp-12	14	21	pulmonary	pulmonary	ADJ
dhrp-12	14	22	embolism	embolism	NOUN
dhrp-12	14	23	rate	rate	NOUN
dhrp-12	14	24	of	of	ADP
dhrp-12	14	25	13	13	NUM
dhrp-12	14	26	%	%	NOUN
dhrp-12	14	27	.	.	PUNCT
dhrp-12	15	1	of	of	ADP
dhrp-12	15	2	equal	equal	ADJ
dhrp-12	15	3	concern	concern	NOUN
dhrp-12	15	4	is	be	AUX
dhrp-12	15	5	the	the	DET
dhrp-12	15	6	observation	observation	NOUN
dhrp-12	15	7	that	that	PRON
dhrp-12	15	8	pooled	pool	VERB
dhrp-12	15	9	odds	odd	NOUN
dhrp-12	15	10	of	of	ADP
dhrp-12	15	11	mortality	mortality	NOUN
dhrp-12	15	12	are	be	AUX
dhrp-12	15	13	74	74	NUM
dhrp-12	15	14	%	%	NOUN
dhrp-12	15	15	higher	high	ADJ
dhrp-12	15	16	among	among	ADP
dhrp-12	15	17	patients	patient	NOUN
dhrp-12	15	18	with	with	ADP
dhrp-12	15	19	te	te	PROPN
dhrp-12	15	20	and	and	CCONJ
dhrp-12	15	21	covid-19	covid-19	PROPN
dhrp-12	15	22	as	as	SCONJ
dhrp-12	15	23	compared	compare	VERB
dhrp-12	15	24	to	to	ADP
dhrp-12	15	25	those	those	PRON
dhrp-12	15	26	without	without	ADP
dhrp-12	15	27	te	te	PROPN
dhrp-12	15	28	(	(	PUNCT
dhrp-12	15	29	7	7	NUM
dhrp-12	15	30	)	)	PUNCT
dhrp-12	15	31	.	.	PUNCT
dhrp-12	16	1	of	of	ADP
dhrp-12	16	2	note	note	NOUN
dhrp-12	16	3	is	be	AUX
dhrp-12	16	4	the	the	DET
dhrp-12	16	5	fact	fact	NOUN
dhrp-12	16	6	that	that	SCONJ
dhrp-12	16	7	the	the	DET
dhrp-12	16	8	risk	risk	NOUN
dhrp-12	16	9	of	of	ADP
dhrp-12	16	10	developing	develop	VERB
dhrp-12	16	11	blood	blood	NOUN
dhrp-12	16	12	clots	clot	NOUN
dhrp-12	16	13	for	for	ADP
dhrp-12	16	14	women	woman	NOUN
dhrp-12	16	15	of	of	ADP
dhrp-12	16	16	childbearing	childbeare	VERB
dhrp-12	16	17	age	age	NOUN
dhrp-12	16	18	using	use	VERB
dhrp-12	16	19	birth	birth	NOUN
dhrp-12	16	20	control	control	NOUN
dhrp-12	16	21	pills	pill	NOUN
dhrp-12	16	22	is	be	AUX
dhrp-12	16	23	much	much	ADV
dhrp-12	16	24	higher	high	ADJ
dhrp-12	16	25	than	than	ADP
dhrp-12	16	26	that	that	PRON
dhrp-12	16	27	observed	observe	VERB
dhrp-12	16	28	after	after	ADP
dhrp-12	16	29	vaccination	vaccination	NOUN
dhrp-12	16	30	with	with	ADP
dhrp-12	16	31	j&j	j&j	PROPN
dhrp-12	16	32	jansen	jansen	PROPN
dhrp-12	16	33	covid-19	covid-19	PROPN
dhrp-12	16	34	vaccine	vaccine	NOUN
dhrp-12	16	35	(	(	PUNCT
dhrp-12	16	36	8)	8)	NUM
dhrp-12	16	37	.	.	PUNCT
dhrp-12	17	1	equally	equally	ADV
dhrp-12	17	2	,	,	PUNCT
dhrp-12	17	3	the	the	DET
dhrp-12	17	4	risk	risk	NOUN
dhrp-12	17	5	of	of	ADP
dhrp-12	17	6	blood	blood	NOUN
dhrp-12	17	7	clots	clot	NOUN
dhrp-12	17	8	associated	associate	VERB
dhrp-12	17	9	with	with	ADP
dhrp-12	17	10	cigarette	cigarette	NOUN
dhrp-12	17	11	smoking	smoking	NOUN
dhrp-12	17	12	is	be	AUX
dhrp-12	17	13	higher	high	ADJ
dhrp-12	17	14	than	than	ADP
dhrp-12	17	15	that	that	PRON
dhrp-12	17	16	observed	observe	VERB
dhrp-12	17	17	after	after	ADP
dhrp-12	17	18	vaccination	vaccination	NOUN
dhrp-12	17	19	with	with	ADP
dhrp-12	17	20	j&j	j&j	PROPN
dhrp-12	17	21	jansen	jansen	PROPN
dhrp-12	17	22	covid-19	covid-19	PROPN
dhrp-12	17	23	vaccine	vaccine	NOUN
dhrp-12	17	24	(	(	PUNCT
dhrp-12	17	25	9	9	NUM
dhrp-12	17	26	)	)	PUNCT
dhrp-12	17	27	.	.	PUNCT
dhrp-12	18	1	while	while	SCONJ
dhrp-12	18	2	the	the	DET
dhrp-12	18	3	precautionary	precautionary	ADJ
dhrp-12	18	4	measures	measure	NOUN
dhrp-12	18	5	taken	take	VERB
dhrp-12	18	6	by	by	ADP
dhrp-12	18	7	the	the	DET
dhrp-12	18	8	cdc	cdc	PROPN
dhrp-12	18	9	and	and	CCONJ
dhrp-12	18	10	the	the	DET
dhrp-12	18	11	fda	fda	PROPN
dhrp-12	18	12	to	to	PART
dhrp-12	18	13	examine	examine	VERB
dhrp-12	18	14	the	the	DET
dhrp-12	18	15	data	datum	NOUN
dhrp-12	18	16	in	in	ADP
dhrp-12	18	17	detail	detail	NOUN
dhrp-12	18	18	is	be	AUX
dhrp-12	18	19	in	in	ADP
dhrp-12	18	20	the	the	DET
dhrp-12	18	21	best	good	ADJ
dhrp-12	18	22	interest	interest	NOUN
dhrp-12	18	23	of	of	ADP
dhrp-12	18	24	the	the	DET
dhrp-12	18	25	public	public	NOUN
dhrp-12	18	26	,	,	PUNCT
dhrp-12	18	27	it	it	PRON
dhrp-12	18	28	must	must	AUX
dhrp-12	18	29	be	be	AUX
dhrp-12	18	30	argued	argue	VERB
dhrp-12	18	31	that	that	SCONJ
dhrp-12	18	32	the	the	DET
dhrp-12	18	33	low	low	ADJ
dhrp-12	18	34	risk	risk	NOUN
dhrp-12	18	35	of	of	ADP
dhrp-12	18	36	blood	blood	NOUN
dhrp-12	18	37	clot	clot	NOUN
dhrp-12	18	38	following	follow	VERB
dhrp-12	18	39	vaccination	vaccination	NOUN
dhrp-12	18	40	with	with	ADP
dhrp-12	18	41	j&j	j&j	PROPN
dhrp-12	18	42	jansen	jansen	PROPN
dhrp-12	18	43	covid-19	covid-19	PROPN
dhrp-12	18	44	vaccine	vaccine	NOUN
dhrp-12	18	45	as	as	SCONJ
dhrp-12	18	46	compared	compare	VERB
dhrp-12	18	47	to	to	ADP
dhrp-12	18	48	that	that	DET
dhrp-12	18	49	following	follow	VERB
dhrp-12	18	50	infection	infection	NOUN
dhrp-12	18	51	with	with	ADP
dhrp-12	18	52	sars	sar	NOUN
dhrp-12	18	53	-	-	PUNCT
dhrp-12	18	54	cov-2	cov-2	PART
dhrp-12	18	55	may	may	AUX
dhrp-12	18	56	justify	justify	VERB
dhrp-12	18	57	its	its	PRON
dhrp-12	18	58	continued	continue	VERB
dhrp-12	18	59	use	use	NOUN
dhrp-12	18	60	to	to	PART
dhrp-12	18	61	vaccinate	vaccinate	VERB
dhrp-12	18	62	people	people	NOUN
dhrp-12	18	63	as	as	ADP
dhrp-12	18	64	a	a	DET
dhrp-12	18	65	means	means	NOUN
dhrp-12	18	66	to	to	PART
dhrp-12	18	67	prevent	prevent	VERB
dhrp-12	18	68	infection	infection	NOUN
dhrp-12	18	69	and	and	CCONJ
dhrp-12	18	70	subsequent	subsequent	ADJ
dhrp-12	18	71	hospitalization	hospitalization	NOUN
dhrp-12	18	72	.	.	PUNCT
dhrp-12	19	1	references	reference	NOUN
dhrp-12	19	2	1	1	NUM
dhrp-12	19	3	.	.	PUNCT
dhrp-12	20	1	covid-19	covid-19	PROPN
dhrp-12	20	2	dashboard	dashboard	NOUN
dhrp-12	20	3	by	by	ADP
dhrp-12	20	4	the	the	DET
dhrp-12	20	5	center	center	NOUN
dhrp-12	20	6	for	for	ADP
dhrp-12	20	7	systems	system	NOUN
dhrp-12	20	8	science	science	NOUN
dhrp-12	20	9	and	and	CCONJ
dhrp-12	20	10	engineering	engineering	NOUN
dhrp-12	20	11	at	at	ADP
dhrp-12	20	12	johns	johns	PROPN
dhrp-12	20	13	hopkins	hopkins	PROPN
dhrp-12	20	14	university	university	PROPN
dhrp-12	20	15	.	.	PUNCT
dhrp-12	21	1	april	april	PROPN
dhrp-12	21	2	16	16	NUM
dhrp-12	21	3	,	,	PUNCT
dhrp-12	21	4	2021	2021	NUM
dhrp-12	21	5	;	;	PUNCT
dhrp-12	21	6	12:01	12:01	NUM
dhrp-12	21	7	pm	pm	NOUN
dhrp-12	21	8	cst	cst	PROPN
dhrp-12	21	9	.	.	PUNCT
dhrp-12	22	1	https://coronavirus.jhu.edu/map.html	https://coronavirus.jhu.edu/map.html	PROPN
dhrp-12	22	2	2	2	NUM
dhrp-12	22	3	.	.	NOUN
dhrp-12	22	4	letter	letter	NOUN
dhrp-12	22	5	of	of	ADP
dhrp-12	22	6	emergency	emergency	NOUN
dhrp-12	22	7	use	use	NOUN
dhrp-12	22	8	authorization	authorization	NOUN
dhrp-12	22	9	from	from	ADP
dhrp-12	22	10	rear	rear	ADJ
dhrp-12	22	11	admiral	admiral	PROPN
dhrp-12	22	12	denise	denise	PROPN
dhrp-12	22	13	m.	m.	PROPN
dhrp-12	22	14	hinton	hinton	PROPN
dhrp-12	22	15	to	to	ADP
dhrp-12	22	16	janssen	janssen	PROPN
dhrp-12	22	17	biotech	biotech	PROPN
dhrp-12	22	18	,	,	PUNCT
dhrp-12	22	19	inc	inc	PROPN
dhrp-12	22	20	.	.	PROPN
dhrp-12	22	21	,	,	PUNCT
dhrp-12	22	22	dated	date	VERB
dhrp-12	22	23	february	february	PROPN
dhrp-12	22	24	27	27	NUM
dhrp-12	22	25	,	,	PUNCT
dhrp-12	22	26	2021	2021	NUM
dhrp-12	22	27	.	.	PUNCT
dhrp-12	22	28	https://www.fda.gov/media/146303/download	https://www.fda.gov/media/146303/download	X
dhrp-12	23	1	3	3	X
dhrp-12	23	2	.	.	PUNCT
dhrp-12	23	3	vaccines	vaccine	NOUN
dhrp-12	23	4	and	and	CCONJ
dhrp-12	23	5	related	related	ADJ
dhrp-12	23	6	biological	biological	ADJ
dhrp-12	23	7	products	product	NOUN
dhrp-12	23	8	advisory	advisory	NOUN
dhrp-12	23	9	committee	committee	NOUN
dhrp-12	23	10	meeting	meeting	NOUN
dhrp-12	23	11	february	february	PROPN
dhrp-12	23	12	26	26	NUM
dhrp-12	23	13	,	,	PUNCT
dhrp-12	23	14	2021	2021	NUM
dhrp-12	23	15	.	.	PUNCT
dhrp-12	24	1	fda	fda	PROPN
dhrp-12	24	2	briefing	briefing	PROPN
dhrp-12	24	3	document	document	NOUN
dhrp-12	24	4	janssen	janssen	PROPN
dhrp-12	24	5	https://coronavirus.jhu.edu/map.html	https://coronavirus.jhu.edu/map.html	PROPN
dhrp-12	24	6	https://www.fda.gov/media/146303/download	https://www.fda.gov/media/146303/download	ADV
dhrp-12	24	7	dhrp	dhrp	ADJ
dhrp-12	24	8	,	,	PUNCT
dhrp-12	24	9	2021	2021	NUM
dhrp-12	24	10	,	,	PUNCT
dhrp-12	24	11	vol	vol	NOUN
dhrp-12	24	12	.	.	NOUN
dhrp-12	24	13	1	1	NUM
dhrp-12	24	14	(	(	PUNCT
dhrp-12	24	15	s2	s2	PROPN
dhrp-12	24	16	)	)	PUNCT
dhrp-12	24	17	1	1	NUM
dhrp-12	24	18	-	-	SYM
dhrp-12	24	19	2	2	NUM
dhrp-12	24	20	editorial	editorial	NOUN
dhrp-12	24	21	http://dhrproceedings.org	http://dhrproceedings.org	PROPN
dhrp-12	24	22	2	2	NUM
dhrp-12	24	23	©	©	PROPN
dhrp-12	24	24	dhr	dhr	PROPN
dhrp-12	24	25	health	health	PROPN
dhrp-12	24	26	institute	institute	PROPN
dhrp-12	24	27	for	for	ADP
dhrp-12	24	28	research	research	NOUN
dhrp-12	24	29	and	and	CCONJ
dhrp-12	24	30	development	development	NOUN
dhrp-12	24	31	ad26.cov2.s	ad26.cov2.s	X
dhrp-12	24	32	vaccine	vaccine	NOUN
dhrp-12	24	33	for	for	ADP
dhrp-12	24	34	the	the	DET
dhrp-12	24	35	prevention	prevention	NOUN
dhrp-12	24	36	of	of	ADP
dhrp-12	24	37	covid-19	covid-19	PROPN
dhrp-12	24	38	.	.	PUNCT
dhrp-12	24	39	https://www.fda.gov/media/146217/download	https://www.fda.gov/media/146217/download	PROPN
dhrp-12	25	1	4	4	X
dhrp-12	25	2	.	.	PUNCT
dhrp-12	25	3	joint	joint	ADJ
dhrp-12	25	4	cdc	cdc	PROPN
dhrp-12	25	5	and	and	CCONJ
dhrp-12	25	6	fda	fda	PROPN
dhrp-12	25	7	statement	statement	NOUN
dhrp-12	25	8	on	on	ADP
dhrp-12	25	9	johnson	johnson	PROPN
dhrp-12	25	10	&	&	CCONJ
dhrp-12	25	11	johnson	johnson	PROPN
dhrp-12	25	12	covid19	covid19	PROPN
dhrp-12	25	13	vaccine	vaccine	PROPN
dhrp-12	25	14	.	.	PUNCT
dhrp-12	26	1	https://www.fda.gov/news-events/pressannouncements/joint-cdc-and-fda-statement-johnson-johnsoncovid-19-vaccine	https://www.fda.gov/news-events/pressannouncements/joint-cdc-and-fda-statement-johnson-johnsoncovid-19-vaccine	PROPN
dhrp-12	26	2	5	5	NUM
dhrp-12	26	3	.	.	PUNCT
dhrp-12	26	4	masuhr	masuhr	PROPN
dhrp-12	26	5	f	f	PROPN
dhrp-12	26	6	,	,	PUNCT
dhrp-12	26	7	einhäupl	einhäupl	PROPN
dhrp-12	26	8	k.	k.	PROPN
dhrp-12	26	9	treatment	treatment	NOUN
dhrp-12	26	10	of	of	ADP
dhrp-12	26	11	cerebral	cerebral	ADJ
dhrp-12	26	12	venous	venous	ADJ
dhrp-12	26	13	and	and	CCONJ
dhrp-12	26	14	sinus	sinus	NOUN
dhrp-12	26	15	thrombosis	thrombosis	NOUN
dhrp-12	26	16	.	.	PUNCT
dhrp-12	27	1	front	front	ADJ
dhrp-12	27	2	neurol	neurol	PROPN
dhrp-12	27	3	neurosci	neurosci	PROPN
dhrp-12	27	4	.	.	PUNCT
dhrp-12	28	1	2008;23:132	2008;23:132	X
dhrp-12	28	2	-	-	SYM
dhrp-12	28	3	43	43	NUM
dhrp-12	28	4	.	.	PUNCT
dhrp-12	29	1	doi	doi	NOUN
dhrp-12	29	2	:	:	PUNCT
dhrp-12	29	3	10.1159/000111375	10.1159/000111375	NUM
dhrp-12	29	4	.	.	PUNCT
dhrp-12	30	1	pmid	pmid	NOUN
dhrp-12	30	2	:	:	PUNCT
dhrp-12	30	3	18004059	18004059	NUM
dhrp-12	30	4	.	.	PUNCT
dhrp-12	31	1	6	6	X
dhrp-12	31	2	.	.	X
dhrp-12	31	3	cdc	cdc	PROPN
dhrp-12	31	4	recommendation	recommendation	NOUN
dhrp-12	31	5	to	to	PART
dhrp-12	31	6	pause	pause	VERB
dhrp-12	31	7	use	use	NOUN
dhrp-12	31	8	of	of	ADP
dhrp-12	31	9	johnson	johnson	PROPN
dhrp-12	31	10	&	&	CCONJ
dhrp-12	31	11	johnson	johnson	PROPN
dhrp-12	31	12	’s	’s	PART
dhrp-12	31	13	janssen	janssen	PROPN
dhrp-12	31	14	covid-19	covid-19	PROPN
dhrp-12	31	15	vaccine	vaccine	NOUN
dhrp-12	31	16	.	.	PUNCT
dhrp-12	32	1	https://www.cdc.gov/coronavirus/2019ncov/vaccines/safety/jjupdate.html	https://www.cdc.gov/coronavirus/2019ncov/vaccines/safety/jjupdate.html	PROPN
dhrp-12	32	2	7	7	NUM
dhrp-12	32	3	.	.	PUNCT
dhrp-12	32	4	malas	malas	PROPN
dhrp-12	32	5	bm	bm	PROPN
dhrp-12	32	6	,	,	PUNCT
dhrp-12	32	7	naazie	naazie	PROPN
dhrp-12	32	8	,	,	PUNCT
dhrp-12	32	9	ih	ih	X
dhrp-12	32	10	,	,	PUNCT
dhrp-12	32	11	et.al	et.al	PROPN
dhrp-12	32	12	.	.	PUNCT
dhrp-12	33	1	thromboembolism	thromboembolism	NOUN
dhrp-12	33	2	risk	risk	NOUN
dhrp-12	33	3	of	of	ADP
dhrp-12	33	4	covid-19	covid-19	PROPN
dhrp-12	33	5	is	be	AUX
dhrp-12	33	6	high	high	ADJ
dhrp-12	33	7	and	and	CCONJ
dhrp-12	33	8	associated	associate	VERB
dhrp-12	33	9	with	with	ADP
dhrp-12	33	10	a	a	DET
dhrp-12	33	11	higher	high	ADJ
dhrp-12	33	12	risk	risk	NOUN
dhrp-12	33	13	of	of	ADP
dhrp-12	33	14	mortality	mortality	NOUN
dhrp-12	33	15	:	:	PUNCT
dhrp-12	33	16	a	a	DET
dhrp-12	33	17	systematic	systematic	ADJ
dhrp-12	33	18	review	review	NOUN
dhrp-12	33	19	and	and	CCONJ
dhrp-12	33	20	meta	meta	ADJ
dhrp-12	33	21	-	-	PUNCT
dhrp-12	33	22	analysis	analysis	NOUN
dhrp-12	33	23	.	.	PUNCT
dhrp-12	34	1	eclinicalmedicine	eclinicalmedicine	PROPN
dhrp-12	34	2	.	.	PUNCT
dhrp-12	35	1	2020	2020	NUM
dhrp-12	35	2	;	;	PUNCT
dhrp-12	35	3	29	29	NUM
dhrp-12	35	4	-	-	SYM
dhrp-12	35	5	30	30	NUM
dhrp-12	35	6	.	.	PUNCT
dhrp-12	36	1	doi	doi	NOUN
dhrp-12	36	2	:	:	PUNCT
dhrp-12	36	3	https://doi.org/10.1016/j.eclinm.2020.100639	https://doi.org/10.1016/j.eclinm.2020.100639	PROPN
dhrp-12	36	4	8	8	NUM
dhrp-12	36	5	.	.	PUNCT
dhrp-12	37	1	sidney	sidney	PROPN
dhrp-12	37	2	s	s	PROPN
dhrp-12	37	3	,	,	PUNCT
dhrp-12	37	4	cheetham	cheetham	PROPN
dhrp-12	37	5	tc	tc	PROPN
dhrp-12	37	6	,	,	PUNCT
dhrp-12	37	7	et.al	et.al	PROPN
dhrp-12	37	8	.	.	PUNCT
dhrp-12	38	1	recent	recent	ADJ
dhrp-12	38	2	combined	combined	ADJ
dhrp-12	38	3	hormonal	hormonal	ADJ
dhrp-12	38	4	contraceptives	contraceptive	NOUN
dhrp-12	38	5	(	(	PUNCT
dhrp-12	38	6	chcs	chcs	PROPN
dhrp-12	38	7	)	)	PUNCT
dhrp-12	38	8	and	and	CCONJ
dhrp-12	38	9	the	the	DET
dhrp-12	38	10	risk	risk	NOUN
dhrp-12	38	11	of	of	ADP
dhrp-12	38	12	thromboembolism	thromboembolism	NOUN
dhrp-12	38	13	and	and	CCONJ
dhrp-12	38	14	other	other	ADJ
dhrp-12	38	15	cardiovascular	cardiovascular	ADJ
dhrp-12	38	16	events	event	NOUN
dhrp-12	38	17	in	in	ADP
dhrp-12	38	18	new	new	ADJ
dhrp-12	38	19	users	user	NOUN
dhrp-12	38	20	.	.	PUNCT
dhrp-12	39	1	contraception	contraception	NOUN
dhrp-12	39	2	.	.	PUNCT
dhrp-12	40	1	2013	2013	NUM
dhrp-12	40	2	jan;87(1):93	jan;87(1):93	NOUN
dhrp-12	40	3	-	-	PUNCT
dhrp-12	40	4	100	100	NUM
dhrp-12	40	5	.	.	PUNCT
dhrp-12	41	1	doi	doi	NOUN
dhrp-12	41	2	:	:	PUNCT
dhrp-12	41	3	10.1016	10.1016	NUM
dhrp-12	41	4	/	/	SYM
dhrp-12	41	5	j.contraception.2012.09.015	j.contraception.2012.09.015	PROPN
dhrp-12	41	6	.	.	PUNCT
dhrp-12	42	1	epub	epub	PROPN
dhrp-12	42	2	2012	2012	NUM
dhrp-12	42	3	oct	oct	NOUN
dhrp-12	42	4	19	19	NUM
dhrp-12	42	5	.	.	PUNCT
dhrp-12	43	1	pmid	pmid	NOUN
dhrp-12	43	2	:	:	PUNCT
dhrp-12	43	3	23083525	23083525	NUM
dhrp-12	43	4	.	.	PUNCT
dhrp-12	44	1	9	9	X
dhrp-12	44	2	.	.	X
dhrp-12	44	3	cheng	cheng	PROPN
dhrp-12	44	4	y	y	PROPN
dhrp-12	44	5	-	-	PROPN
dhrp-12	44	6	j	j	PROPN
dhrp-12	44	7	,	,	PUNCT
dhrp-12	44	8	liu	liu	PROPN
dhrp-12	44	9	z	z	PROPN
dhrp-12	44	10	-	-	PUNCT
dhrp-12	44	11	h	h	PROPN
dhrp-12	44	12	,	,	PUNCT
dhrp-12	44	13	yao	yao	PROPN
dhrp-12	44	14	f	f	PROPN
dhrp-12	44	15	-	-	PUNCT
dhrp-12	44	16	j	j	PROPN
dhrp-12	44	17	,	,	PUNCT
dhrp-12	44	18	zeng	zeng	PROPN
dhrp-12	44	19	w	w	PROPN
dhrp-12	44	20	-	-	PUNCT
dhrp-12	44	21	t	t	PROPN
dhrp-12	44	22	,	,	PUNCT
dhrp-12	44	23	zheng	zheng	PROPN
dhrp-12	44	24	d	d	PROPN
dhrp-12	44	25	-	-	PUNCT
dhrp-12	44	26	d	d	PROPN
dhrp-12	44	27	,	,	PUNCT
dhrp-12	44	28	dong	dong	PROPN
dhrp-12	44	29	yg	yg	PROPN
dhrp-12	44	30	,	,	PUNCT
dhrp-12	44	31	et	et	PROPN
dhrp-12	44	32	al	al	PROPN
dhrp-12	44	33	.	.	PROPN
dhrp-12	45	1	(	(	PUNCT
dhrp-12	45	2	2013	2013	NUM
dhrp-12	45	3	)	)	PUNCT
dhrp-12	45	4	current	current	ADJ
dhrp-12	45	5	and	and	CCONJ
dhrp-12	45	6	former	former	ADJ
dhrp-12	45	7	smoking	smoking	NOUN
dhrp-12	45	8	and	and	CCONJ
dhrp-12	45	9	risk	risk	NOUN
dhrp-12	45	10	for	for	ADP
dhrp-12	45	11	venous	venous	ADJ
dhrp-12	45	12	thromboembolism	thromboembolism	NOUN
dhrp-12	45	13	:	:	PUNCT
dhrp-12	45	14	a	a	DET
dhrp-12	45	15	systematic	systematic	ADJ
dhrp-12	45	16	review	review	NOUN
dhrp-12	45	17	and	and	CCONJ
dhrp-12	45	18	metaanalysis	metaanalysis	NOUN
dhrp-12	45	19	.	.	PUNCT
dhrp-12	46	1	plos	plos	PROPN
dhrp-12	46	2	med	med	PROPN
dhrp-12	46	3	10(9	10(9	NUM
dhrp-12	46	4	):	):	PUNCT
dhrp-12	46	5	e1001515	e1001515	NOUN
dhrp-12	46	6	.	.	PUNCT
dhrp-12	46	7	https://doi.org/10.1371/journal.pmed.1001515	https://doi.org/10.1371/journal.pmed.1001515	PROPN
dhrp-12	46	8	sohail	sohail	PROPN
dhrp-12	46	9	rao	rao	PROPN
dhrp-12	46	10	,	,	PUNCT
dhrp-12	46	11	md	md	PROPN
dhrp-12	46	12	,	,	PUNCT
dhrp-12	46	13	ma	ma	PROPN
dhrp-12	46	14	,	,	PUNCT
dhrp-12	46	15	dphil	dphil	ADJ
dhrp-12	46	16	executive	executive	ADJ
dhrp-12	46	17	vice	vice	NOUN
dhrp-12	46	18	president	president	NOUN
dhrp-12	46	19	,	,	PUNCT
dhrp-12	46	20	dhr	dhr	PROPN
dhrp-12	46	21	health	health	PROPN
dhrp-12	46	22	,	,	PUNCT
dhrp-12	46	23	5501	5501	NUM
dhrp-12	46	24	s.	s.	PROPN
dhrp-12	46	25	mccoll	mccoll	PROPN
dhrp-12	46	26	road	road	PROPN
dhrp-12	46	27	,	,	PUNCT
dhrp-12	46	28	edinburg	edinburg	PROPN
dhrp-12	46	29	,	,	PUNCT
dhrp-12	46	30	texas	texas	PROPN
dhrp-12	46	31	president	president	PROPN
dhrp-12	46	32	&	&	CCONJ
dhrp-12	46	33	chief	chief	ADJ
dhrp-12	46	34	executive	executive	ADJ
dhrp-12	46	35	officer	officer	NOUN
dhrp-12	46	36	,	,	PUNCT
dhrp-12	46	37	dhr	dhr	PROPN
dhrp-12	46	38	health	health	PROPN
dhrp-12	46	39	institute	institute	PROPN
dhrp-12	46	40	for	for	ADP
dhrp-12	46	41	research	research	PROPN
dhrp-12	46	42	&	&	CCONJ
dhrp-12	46	43	development	development	PROPN
dhrp-12	46	44	,	,	PUNCT
dhrp-12	46	45	5323	5323	NUM
dhrp-12	46	46	s.	s.	PROPN
dhrp-12	46	47	mccoll	mccoll	PROPN
dhrp-12	46	48	road	road	PROPN
dhrp-12	46	49	,	,	PUNCT
dhrp-12	46	50	edinburg	edinburg	PROPN
dhrp-12	46	51	,	,	PUNCT
dhrp-12	46	52	texas	texas	PROPN
dhrp-12	46	53	corresponding	corresponding	PROPN
dhrp-12	46	54	author	author	NOUN
dhrp-12	46	55	email	email	NOUN
dhrp-12	46	56	:	:	PUNCT
dhrp-12	46	57	s.rao@dhr-rgv.com	s.rao@dhr-rgv.com	X
dhrp-12	46	58	disclosures	disclosure	NOUN
dhrp-12	46	59	:	:	PUNCT
dhrp-12	46	60	none	none	NOUN
dhrp-12	46	61	orcid	orcid	NOUN
dhrp-12	46	62	:	:	PUNCT
dhrp-12	46	63	sohail	sohail	PROPN
dhrp-12	46	64	rao	rao	PROPN
dhrp-12	46	65	:	:	PUNCT
dhrp-12	46	66	https://orcid.org/0000-0001-50279992	https://orcid.org/0000-0001-50279992	PROPN
dhrp-12	46	67	https://www.fda.gov/media/146217/download	https://www.fda.gov/media/146217/download	PROPN
dhrp-12	46	68	https://www.fda.gov/news-events/press-announcements/joint-cdc-and-fda-statement-johnson-johnson-covid-19-vaccine	https://www.fda.gov/news-events/press-announcements/joint-cdc-and-fda-statement-johnson-johnson-covid-19-vaccine	PROPN
dhrp-12	46	69	https://www.fda.gov/news-events/press-announcements/joint-cdc-and-fda-statement-johnson-johnson-covid-19-vaccine	https://www.fda.gov/news-events/press-announcements/joint-cdc-and-fda-statement-johnson-johnson-covid-19-vaccine	PROPN
dhrp-12	46	70	https://www.fda.gov/news-events/press-announcements/joint-cdc-and-fda-statement-johnson-johnson-covid-19-vaccine	https://www.fda.gov/news-events/press-announcements/joint-cdc-and-fda-statement-johnson-johnson-covid-19-vaccine	NOUN
dhrp-12	46	71	https://doi.org/10.1159/000111375	https://doi.org/10.1159/000111375	VERB
dhrp-12	47	1	https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/jjupdate.html	https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/jjupdate.html	PROPN
dhrp-12	47	2	https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/jjupdate.html	https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/jjupdate.html	PROPN
dhrp-12	47	3	https://doi.org/10.1016/j.eclinm.2020.100639	https://doi.org/10.1016/j.eclinm.2020.100639	PROPN
dhrp-12	47	4	https://doi.org/10.1371/journal.pmed.1001515	https://doi.org/10.1371/journal.pmed.1001515	VERB
dhrp-12	47	5	https://orcid.org/0000-0001-5027-9992	https://orcid.org/0000-0001-5027-9992	PROPN
dhrp-12	47	6	https://orcid.org/0000-0001-5027-9992	https://orcid.org/0000-0001-5027-9992	PROPN